Population prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in the Netherlands. Should asymptomatic persons be tested during population-based Chlamydia screening also for gonorrhoea or only if chlamydial infection is found?

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  van Bergen, Jan E A M ^a,f   Spaargaren, Joke ^h   Götz, Hannelore M ^b   Veldhuijzen, Irene K ^b   Bindels, Patrick J E ^f   Coenen, Ton J ^a   Broer, Jan ^d   de Groot, Fetzen ^d   Hoebe, Christian J P A ^c   Richardus, Jan Hendrik ^b,e   van Schaik, Daniel ^a   Verhooren, Marije ^g  

^a National Institute for STI and AIDS Control in the Netherlands   (Netherlands)

^b Public Health Service of the Rotterdam Region   (Netherlands)

^c Municipal Public Health Service South Limburg   (Netherlands)

^d Municipal Public Health Service Groningen   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f ACADEMIC MEDICAL CENTER   (Netherlands)

^g Municipal Public Health Service Hart van Brabant   (Netherlands)

^h MUNICIPAL HEALTH SERVICE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GONORRHEA; HIGH RISK POPULATION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; NEISSERIA GONORRHOEAE; NETHERLANDS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; URBAN AREA;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; GONORRHEA; HUMANS; MALE; NETHERLANDS; PREVALENCE; RISK FACTORS; URBAN POPULATION;

EID: 33646182037     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-42     Document Type: Article

References (22)

1. Stamm WE: Chlamydia trachomatis infections of the adult. In Sexually Transmitted Diseases 3rd edition. Edited by: Holmes KK, Sparling PF, Mardh PA. New York: McGraw-Hill; 1999.
2. Weström L, Joesoef R: Pelvic inflammatory disease and fertility: a cohort of 1,844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex Transm Dis 1992, 19:185-92.
3. Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes KK, Stamm WE: Prevention of pelvic inflammatory disease by screening for chlamydial infection. New Eng J Med 1996, 334:1362-67.
4. Østergaard L, Andersen B, Moller JK, Olesen F: Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: A cluster-randomized 1-year follow-up study. Clin Infect Dis 2000, 31:951-57.
5. Ford CA, Viadro CI, Miller WC: Testing for Chlamydial and Gonococcal Infections Outside of Clinic Settings. A summary of the literature. Sex Transm Dis 2004, 1:38-51. Review
6. LaMontagne DS, Fenton KA, Randall S, Anderson S, Carter P: Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect 2004, 80:335-41.
7. van Bergen JEAM, Kerssens JJ, Schellevis FG, Sandfort TG, Bindels PJ: Prevalence of STI related consultations in general practice in the Netherlands: results from the second Dutch National Survey of General Practice. Br J Pract 2006, 56(523):104-109.
8. Van Bergen JE, Gotz HM, Richardus JH, Hoebe CJPA, Broer J, Coenen AJ: Prevalence of urogenital Chlamydia trachomatis increases significantly with level of urbanisation and suggests targeed screening approaches: results from the first national population based study in the Netherlands. Sex Transm Infect 2005, 81:17-239.
9. Farrell DJ: Evaluation of AMPLICOR Neisseria gonorrhoeae PCR using cppB nested PCR and 16SrRNA PCR. J Clin Microbiol 1999, 37(2):386-90.
10. Bruisten SM, Noordhoek GT, van den Brule AJ, Duim B, Boel CH, El-Faouzi K, du Maine R, Mulder S, Luijt D, Schirm J: Multicenter validation of the cppB gene as a PCR target for detection of Neisseria gonorrhoeae. J Clin Microbiol 2004, 42(9):4332-4.
11. Götz HM, van Bergen JE, Veldhuijzen IK, Broer J, Hoebe CJ, Steyerberg EW, Coenen AJ, de Groot F, Verhooren MJ, van Schaik DT, Richardus JH: A prediction rule for selective screening of Chlamydia trachomatis infection. Sex Transm Infect 2005, 81:24-30.
12. Fennema JSA: Annual report 2002 STI-clinic Municipal Public Health Service Amsterdam Amsterdam, The Netherlands; 2003.
13. Low N, Sterne JA, Barlow D: Inequalities in rates of gonorrhoea and chlamydia between black ethnic groups in south east London: cross sectional study. Sex Transm Infect 2001, 77(1):15-20.
14. Aral SO: Understanding racial-ethnic and societal differentials in STI. Sex Transm Infect 2002, 78(1):2-4.
15. Aral SO, Hughes JP, Stoner B, Whittington W, Handsfield HH, Anderson RM, Holmes KK: Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health 1999, 89:825-833.
16. Creighton S, Tenant-Flowers M, Taylor CB, Miller R, Low N: Coinfection with gonorrhoea and chlamydia: how much is there and what does it mean? Int J STD AIDS 2003, 14(2):109-13.
17. Dragovic B, Greaves K, Vashisht A, Straughair G, Sabin C, Smith NA: Chlamydial co-infection among patients with gonorrhoea. Int J STD AIDS 2002, 13(4):261-3.
18. Centers for Disease Control and Prevention: Sexually Transmitted Infections guidelines. MMWR 2002, 51(No. RR-6): [http://www.cdc.gov/STD/treatment/TOC2002TG.htm].
19. Harindra V, Tobin JM, Underhill G: Opportunistic chlamydia screening: should positive patients be screened for co-infections? Int J STD AIDS 2002, 13(12):821-5.
20. Miller CW, Ford CA, Morris M, Handcock MS, Schmitz JL, Hobbs MM, Cohen MS, Harris KM, Udry JR: Prevalence of Chlamydial and Gonococcal infection among Young Adults in The United States. JAMA 2004, 291:2229-2236.
21. Ashton MR, Cook RL, Wiesenfeld HC, Krohn MA, Zamborsky T, Scholle SH, Switzer GE: Primary Care Physician Attitudes Regarding Sexually Transmitted Diseases. Sex Transm Dis 2002, 29:246-251.
22. Grimes DA, Schultz K: Uses and abuses of screening tests. Lancet 2002, 359:881-884.